Vancouver BC, March 23, 2020  Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the company entered into a license
Advanced Facility Readies to Combat COVID-19 (Carlsbad, CA) March 23, 2020 – Argonaut Manufacturing Services announced today it has immediate availability for aseptic drug product
New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc. has developed an Armored RNA
Seattle, WA, February 27, 2020 – RareCyte announces a new liquid biopsy blood test for programmed death-ligand 1 (PD-L1), enabling customers to evaluate PD-L1 expression
Active Motif Shanghai (a subsidiary of Active Motif, Inc.), in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpic™
The U.S. Food and Drug Administration today authorized marketing of the first test to detect a genetic condition known as Fragile X Syndrome (FXS), the
MADISON, WI–Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based
Additional Resources Will Support New Product Development and Global Expansion SALT LAKE CITY, UTAH, USA (January 14, 2020) – Carterra® Inc., the world leader in
SEATTLE, Dec. 19, 2019 /PRNewswire/ — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue biopsy analysis platforms with emphasis
SAN DIEGO, CA (December 9, 2019) — GEDmatch, a pioneer in consumer genealogy, today announced that it has joined with forensic genomics firm Verogen, Inc.
Additional Resources Will Support Continued Commercialization of Akoya’s Spatial Biology Platforms CODEX® and Phenoptics™ Company to present at Piper Jaffray 31st Annual Healthcare Conference Akoya Biosciences,
Mark O’Donnell Joins Argonaut Manufacturing Services Board Carlsbad, CA, Nov 05, 2019 – Argonaut Manufacturing Services announced today that Mark O’Donnell has been appointed to